These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1242 related items for PubMed ID: 3723487

  • 1. Effects of oral contraceptives on lipid metabolism.
    Krauss RM.
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
    [Abstract] [Full Text] [Related]

  • 2. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R, Hilliquin P.
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Jan; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pill formulations and their effect on lipid and carbohydrate metabolism.
    Brooks PG.
    J Reprod Med; 1984 Jul; 29(7 Suppl):539-46. PubMed ID: 6481707
    [Abstract] [Full Text] [Related]

  • 7. Women, lipoproteins and cardiovascular disease risk.
    LaRosa JC.
    Can J Cardiol; 1990 May; 6 Suppl B():23B-29B. PubMed ID: 2188715
    [Abstract] [Full Text] [Related]

  • 8. [Lipoprotein metabolism].
    Corvilain B.
    Rev Med Brux; 1997 Feb; 18(1):3-9. PubMed ID: 9132915
    [Abstract] [Full Text] [Related]

  • 9. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH, Walden CE, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Ogilvie JT, Hazzard WR.
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [Abstract] [Full Text] [Related]

  • 10. Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy.
    Burkman RT.
    Fertil Steril; 1988 May; 49(5 Suppl 2):39S-50S. PubMed ID: 3282934
    [Abstract] [Full Text] [Related]

  • 11. Effects of oral contraceptives on circulating lipids and lipoproteins: maximizing benefit, minimizing risk.
    LaRosa JC.
    Int J Fertil; 1989 May; 34 Suppl():71-84. PubMed ID: 2576264
    [Abstract] [Full Text] [Related]

  • 12. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
    Boyet F.
    Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
    [Abstract] [Full Text] [Related]

  • 13. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P, Kannan NK.
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [Abstract] [Full Text] [Related]

  • 14. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 15. Changes in lipoproteins with various sex steroids.
    Teran AZ, Greenblatt RB, Chaddha JS.
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):107-19. PubMed ID: 3306515
    [Abstract] [Full Text] [Related]

  • 16. Oral contraceptives and coronary heart disease.
    Wynn V.
    J Reprod Med; 1991 Mar; 36(3 Suppl):219-25. PubMed ID: 2046075
    [Abstract] [Full Text] [Related]

  • 17. The metabolic impact of oral contraceptives.
    Krauss RM, Burkman RT.
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
    [Abstract] [Full Text] [Related]

  • 18. The transport of triglyceride in the high-density lipoproteins of human plasma.
    Barter PJ, Connor WE.
    J Lab Clin Med; 1975 Feb; 85(2):260-72. PubMed ID: 163284
    [Abstract] [Full Text] [Related]

  • 19. Biology: risk factor modification by OCs and HRT lipids and lipoproteins.
    Godsland IF.
    Maturitas; 2004 Apr 15; 47(4):299-303. PubMed ID: 15063483
    [Abstract] [Full Text] [Related]

  • 20. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA.
    J Ren Nutr; 2009 Jan 15; 19(1):73-7. PubMed ID: 19121776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.